Supplementary Data Table 6 from The Inherited KRAS-variant as a Biomarker of Cetuximab Response in NSCLC
Year: 2023
Type: supplementary-materials
Abstract: Worst Overall Treatment-Related Adverse Event by KRAS Analysis Inclusion Status
Authors: Joanne B. Weidhaas, Chen Hu, Ritsuko Komaki, Gregory A. Masters, George R. Blumenschein, Joe Y. Chang, Bo Lu, Adam P. Dicker, Jeffrey A. Bogart, Yolanda I. Garces, Samir Narayan, Clifford G. Robinson, Vivek S. Kavadi, Joel S. Greenberger, Christopher D. Koprowski, James Welsh, Elizabeth M. Gore, Robert M. MacRae, Rebecca Paulus, Jeffrey D. Bradley
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
OpenAlex ID: W4387540990